PT833903E - Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino - Google Patents

Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino

Info

Publication number
PT833903E
PT833903E PT96923275T PT96923275T PT833903E PT 833903 E PT833903 E PT 833903E PT 96923275 T PT96923275 T PT 96923275T PT 96923275 T PT96923275 T PT 96923275T PT 833903 E PT833903 E PT 833903E
Authority
PT
Portugal
Prior art keywords
bovine
bcv
multivalent
cattle
vaccine
Prior art date
Application number
PT96923275T
Other languages
English (en)
Inventor
Sanjay Kapil
Original Assignee
Univ Kansas State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas State filed Critical Univ Kansas State
Publication of PT833903E publication Critical patent/PT833903E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT96923275T 1995-06-12 1996-06-07 Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino PT833903E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48961495A 1995-06-12 1995-06-12

Publications (1)

Publication Number Publication Date
PT833903E true PT833903E (pt) 2004-11-30

Family

ID=23944554

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96923275T PT833903E (pt) 1995-06-12 1996-06-07 Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino

Country Status (10)

Country Link
US (1) US5916570A (pt)
EP (1) EP0833903B1 (pt)
AT (1) ATE274579T1 (pt)
AU (1) AU705186B2 (pt)
CA (1) CA2224309C (pt)
DE (1) DE69633233T2 (pt)
DK (1) DK0833903T3 (pt)
ES (1) ES2224172T3 (pt)
PT (1) PT833903E (pt)
WO (1) WO1996041874A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0975360B1 (en) * 1997-03-10 2006-08-02 Bayer Corporation Bovine respiratory and enteric coronovirus as a vaccine
AU2001264802A1 (en) 2000-05-21 2001-12-03 University Of North Carolina At Chapel Hill Assembly of large viral genomes and chromosomes from subclones
US6974577B2 (en) * 2001-02-04 2005-12-13 Novartris Ag Inactivated bovine scours vaccines, processes and method of preventing bovine scours
US7906311B2 (en) * 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
GB0217434D0 (en) * 2002-07-27 2002-09-04 Royal Vetinary College Biological material
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
GB0315323D0 (en) * 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
RU2012105524A (ru) * 2009-07-17 2013-08-27 Дзе Борд Оф Риджентс Фор Оклахома Стейт Юниверсити Надъязычные вакцины и аппликаторы
US8440203B2 (en) 2009-11-06 2013-05-14 Intervet Inc. Methods of immunizing pregnant heifers at three months of gestation
KR102243374B1 (ko) * 2019-09-30 2021-04-22 대한민국 소 코로나바이러스, 소 로타바이러스 및 소 바이러스성설사병바이러스에 대한 백신 조성물
KR102234525B1 (ko) * 2020-08-28 2021-03-30 안병철 송아지의 점막관련 전염성 질병을 예방 또는 치료하기 위한 혈청의 제조방법, 상기 방법에 의해 제조된 혈청 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839556A (en) * 1969-11-28 1974-10-01 Univ Nebraska Calf diarrhea virus vaccine and processes
US3838004A (en) * 1970-11-17 1974-09-24 Univ Nebraska Calf diarrhea virus vaccine and processes
US3869547A (en) * 1971-11-10 1975-03-04 Univ Nebraska Calf diarrhea virus vaccine and processes
US3914408A (en) * 1973-10-12 1975-10-21 Univ Nebraska Vaccine for neonatal calf diarrhea

Also Published As

Publication number Publication date
EP0833903B1 (en) 2004-08-25
AU705186B2 (en) 1999-05-20
DE69633233T2 (de) 2005-08-11
EP0833903A1 (en) 1998-04-08
CA2224309C (en) 2011-01-25
AU6383296A (en) 1997-01-09
CA2224309A1 (en) 1996-12-27
WO1996041874A1 (en) 1996-12-27
ES2224172T3 (es) 2005-03-01
DK0833903T3 (da) 2005-01-03
ATE274579T1 (de) 2004-09-15
DE69633233D1 (de) 2004-09-30
EP0833903A4 (en) 1999-03-24
US5916570A (en) 1999-06-29

Similar Documents

Publication Publication Date Title
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
PT815235E (pt) Vacinas para peste
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
ATE271063T1 (de) Purin-l-nukleoside, deren analoga und verwendungen
ES2173300T3 (es) Vacunas de virus vivos prrs de baja patogenicidad y metodos para su preparacion.
PT833903E (pt) Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
ATE79548T1 (de) Herpes simplex virus subunitimpfstoff.
ATE103297T1 (de) Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea.
ATE226829T1 (de) Pharmazeutische zusammensetzung, enthaltend serum-amyloid p-komponenten, zur prophylaxe und therapie von viralen infektionen sowie kit zur detektionvon komplexen zwischen solchen zusammensetzungen und viralen komponenten
BG102809A (en) Vaccine against the reproductive and respiratory syndrome in pigs
ATE416788T1 (de) Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
LU90204I2 (fr) Anatoxine diphtérique anatoxine tétanique trois antigènes coquelucheux purifiés (toxine pertussique tp hémagglutinine filamenteuse (haf) et pertactine (protéine de membrane externe 69 kd) et le principal antigène de surface du virus de l'hépatite b (vhb) purfié (infanrix hepb) et ses dérivés pharmaceutiquement acceptables
Edwards et al. Evidence for an immunocompromising effect of bovine pestivirus on bovid herpesvirus 1 vaccination
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
ES2079851T3 (es) Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas.
JP3109886B2 (ja) 経鼻接種用ワクチン
AR010568A1 (es) Polipeptido, composicion de vacuna, uso del polipeptido en la fabricacion de una composicion, y metodo para producir en un mamifero una respuestainmuno-protectora contra la infeccion de helicobacter pylori
PT1156791E (pt) Bupropiona para tratar doencas virais
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ES2060740T3 (es) Vacunas de virus vivos para la enfermedad de newcastle.
Grachev Long-term use of oral poliovirus vaccine from Sabin strains in the Soviet Union
IT1277926B1 (it) Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
Ashe et al. Inapparent herpes simplex virus infection in inoculated rabbits
ES482549A0 (es) Un metodo para la preparacion de una composicion de virus herpes